Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03572478
Title Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Chicago
Indications

endometrial cancer

prostate cancer

Therapies

Nivolumab + Rucaparib

Nivolumab

Rucaparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field